Global High Throughput Screening (HTS) Market 2020-2024

ハイスループットスクリーニング(HTS)の世界市場2020-2024:製薬・バイオテクノロジー企業、学術・研究機関、CRO

◆タイトル:Global High Throughput Screening (HTS) Market 2020-2024
◆商品コード:IRTNTR44564
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2020年8月
◆ページ数:約120
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、その他
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、ハイスループットスクリーニング(HTS)の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、エンドユーザー別(製薬・バイオテクノロジー企業、学術・研究機関、CRO)分析、顧客状況、地域状況、企業状況、企業分析などの構成でお届けいたします。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・ハイスループットスクリーニング(HTS)の世界市場規模:エンドユーザー別(製薬・バイオテクノロジー企業、学術・研究機関、CRO)
・顧客状況
・地域状況
・企業状況
・企業分析

Global High Throughput Screening Market 2020-2024

Technavio has been monitoring the high throughput screening market and it is poised to grow by $ 15.03 bn during 2020-2024 progressing at a CAGR of 12% during the forecast period. Our reports on high throughput screening market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rise in R&D investments, increasing prevalence of chronic disease, and patent expiration of drugs. In addition, rise in R&D investments is anticipated to boost the growth of the market as well.

The high throughput screening market analysis includes end-user segment and geographic landscapes.

Technavio’s high throughput screening market is segmented as below:

By End-user
• Pharmaceutical and biotechnology companies
• Academic and research institutes
• CROs

By Geographic Landscape
• North America
• Europe
• APAC
• ROW

This study identifies the increasing prevalence of chronic disease as one of the prime reasons driving the high throughput screening market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our high throughput screening market covers the following areas:
• High throughput screening market sizing
• High throughput screening market forecast
• High throughput screening market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading high throughput screening market vendors that include Agilent Technologies Inc., AstraZeneca Plc, Beckman Coulter Inc., Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Charles River Laboratories International Inc., Corning Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., Sartorius AG, Tecan Group Ltd., and Thermo Fisher Scientific Inc. Also, the high throughput screening market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/high-throughput-screening-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【資料の目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by End-user
o Market segments
o Comparison by End-user
o Pharmaceutical and biotechnology companies – Market size and forecast 2019-2024
o Academic and research institutes – Market size and forecast 2019-2024
o CROs – Market size and forecast 2019-2024
o Market opportunity by End-user
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Competitive scenario
o Vendor landscape
o Landscape disruption
o Industry risks
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Agilent Technologies Inc.
o AstraZeneca Plc
o Beckman Coulter Inc.
o Bio-Rad Laboratories Inc.
o Charles River Laboratories International Inc.
o Corning Inc.
o Danaher Corp.
o Eurofins Scientific SE
o F. Hoffmann-La Roche Ltd.
o Merck KGaA
o PerkinElmer Inc.
o Sartorius AG
o Tecan Group Ltd.
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: End user – Market share 2019-2024 (%)
• 22: Comparison by End user
• 23: Pharmaceutical and biotechnology companies – Market size and forecast 2019-2024 ($ million)
• 24: Pharmaceutical and biotechnology companies – Year-over-year growth 2019-2024 (%)
• 25: Academic and research institutes – Market size and forecast 2019-2024 ($ million)
• 26: Academic and research institutes – Year-over-year growth 2019-2024 (%)
• 27: CROs – Market size and forecast 2019-2024 ($ million)
• 28: CROs – Year-over-year growth 2019-2024 (%)
• 29: Market opportunity by End user
• 30: Customer landscape
• 31: Market share by geography 2019-2024 (%)
• 32: Geographic comparison
• 33: North America – Market size and forecast 2019-2024 ($ million)
• 34: North America – Year-over-year growth 2019-2024 (%)
• 35: Europe – Market size and forecast 2019-2024 ($ million)
• 36: Europe – Year-over-year growth 2019-2024 (%)
• 37: APAC – Market size and forecast 2019-2024 ($ million)
• 38: APAC – Year-over-year growth 2019-2024 (%)
• 39: ROW – Market size and forecast 2019-2024 ($ million)
• 40: ROW – Year-over-year growth 2019-2024 (%)
• 41: Key leading countries
• 42: Market opportunity by geography ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: Agilent Technologies Inc. – Overview
• 50: Agilent Technologies Inc. – Business segments
• 51: Agilent Technologies Inc. – Key offerings
• 52: Agilent Technologies Inc. – Key customers
• 53: Agilent Technologies Inc. – Segment focus
• 54: AstraZeneca Plc – Overview
• 55: AstraZeneca Plc – Product and service
• 56: AstraZeneca Plc – Key offerings
• 57: AstraZeneca Plc – Key customers
• 58: AstraZeneca Plc – Segment focus
• 59: Beckman Coulter Inc. – Overview
• 60: Beckman Coulter Inc. – Product and service
• 61: Beckman Coulter Inc. – Key offerings
• 62: Beckman Coulter Inc. – Key customers
• 63: Beckman Coulter Inc. – Segment focus
• 64: Becton, Dickinson and Co. – Overview
• 65: Becton, Dickinson and Co. – Business segments
• 66: Becton, Dickinson and Co. – Key offerings
• 67: Becton, Dickinson and Co. – Key customers
• 68: Becton, Dickinson and Co. – Segment focus
• 69: Bio-Rad Laboratories Inc. – Overview
• 70: Bio-Rad Laboratories Inc. – Business segments
• 71: Bio-Rad Laboratories Inc. – Key offerings
• 72: Bio-Rad Laboratories Inc. – Key customers
• 73: Bio-Rad Laboratories Inc. – Segment focus
• 74: Charles River Laboratories International Inc. – Overview
• 75: Charles River Laboratories International Inc. – Product and service
• 76: Charles River Laboratories International Inc. – Key offerings
• 77: Charles River Laboratories International Inc. – Key customers
• 78: Charles River Laboratories International Inc. – Segment focus
• 79: Corning Inc. – Overview
• 80: Corning Inc. – Business segments
• 81: Corning Inc. – Key offerings
• 82: Corning Inc. – Key customers
• 83: Corning Inc. – Segment focus
• 84: Danaher Corp. – Overview
• 85: Danaher Corp. – Business segments
• 86: Danaher Corp. – Key offerings
• 87: Danaher Corp. – Key customers
• 88: Danaher Corp. – Segment focus
• 89: Eurofins Scientific SE – Overview
• 90: Eurofins Scientific SE – Business segments
• 91: Eurofins Scientific SE – Key offerings
• 92: Eurofins Scientific SE – Key customers
• 93: Eurofins Scientific SE – Segment focus
• 94: F. Hoffmann-La Roche Ltd. – Overview
• 95: F. Hoffmann-La Roche Ltd. – Business segments
• 96: F. Hoffmann-La Roche Ltd. – Key offerings
• 97: F. Hoffmann-La Roche Ltd. – Key customers
• 98: F. Hoffmann-La Roche Ltd. – Segment focus
• 99: Merck KGaA – Overview
• 100: Merck KGaA – Business segments
• 101: Merck KGaA – Key offerings
• 102: Merck KGaA – Key customers
• 103: Merck KGaA – Segment focus
• 104: PerkinElmer Inc. – Overview
• 105: PerkinElmer Inc. – Business segments
• 106: PerkinElmer Inc. – Key offerings
• 107: PerkinElmer Inc. – Key customers
• 108: PerkinElmer Inc. – Segment focus
• 109: Sartorius AG – Overview
• 110: Sartorius AG – Business segments
• 111: Sartorius AG – Key offerings
• 112: Sartorius AG – Key customers
• 113: Sartorius AG – Segment focus
• 114: Tecan Group Ltd. – Overview
• 115: Tecan Group Ltd. – Business segments
• 116: Tecan Group Ltd. – Key offerings
• 117: Tecan Group Ltd. – Key customers
• 118: Tecan Group Ltd. – Segment focus
• 119: Thermo Fisher Scientific Inc. – Overview
• 120: Thermo Fisher Scientific Inc. – Business segments
• 121: Thermo Fisher Scientific Inc. – Key offerings
• 122: Thermo Fisher Scientific Inc. – Key customers
• 123: Thermo Fisher Scientific Inc. – Segment focus
• 124: Currency conversion rates for US$
• 125: Research Methodology
• 126: Validation techniques employed for market sizing
• 127: Information sources
• 128: List of abbreviations



【掲載企業】

Agilent Technologies Inc., AstraZeneca Plc, Beckman Coulter Inc., Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Charles River Laboratories International Inc., Corning Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., Sartorius AG, Tecan Group Ltd., Thermo Fisher Scientific Inc.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[ハイスループットスクリーニング(HTS)の世界市場2020-2024:製薬・バイオテクノロジー企業、学術・研究機関、CRO]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆